ADHD and Social Anxiety in Adults
March 6, 2026 | 8:30am to 10am CT | 1.5 CE credit hours

Live, Interactive, and Virtual (via Zoom)

*Registration for this course CLOSES on Wednesday, March 4, 2026 at 5pm CT. Register for the on-demand course HERE*

CE/CEU credits included: 1.5 (see below for approval details). You must attend at least 90% of this webinar to receive continuing education credits, and attendance is monitored (partial credit not awarded).

Format: Live virtual workshop via Zoom. If you are interested on the on-demand version of this course, click here.

Investment:

• Early registration (until February 6, 2026 at 11:59pm CT) = $35
• Registration fee (February 7, 2026 until registration closes) = $55

Presenter: Kristin Hoff, PsyD, LP, CMPC (see bio below)

Abstract:

Studies indicate an estimated worldwide prevalence of Attention Deficit Hyperactivity Disorder (ADHD) to be 1.6-5% (Popit et al., 2024). Individuals diagnosed with ADHD often meet criteria for additional psychiatric diagnoses (Choi et al., 2022; Mohammedi et al., 2019). In fact, one study found that 80% of adults diagnosed with ADHD also meet criteria for at least one comorbid diagnosis (Seo et al., 2022). Anxiety disorders are commonly co-occurring with ADHD (Fu et al., 2025), and approximately 3.3% of adolescents and adults with ADHD are also diagnosed with social anxiety disorder (SAD; Pehlivanidis et al., 2020). Research on the co-existence of ADHD and SAD demonstrate higher rates of rejection sensitivity (Koyuncu et al., 2017) and challenges in childhood social relationships including stigma, rejection, bullying (Gardner & Gerdes, 2013), and exclusion (Becker, Kneeskern, & Tamm, 2019). Severity of symptoms and impairments may be greater for ADHD inattentive presentation (Koyuncu et al., 2015).

Given that individuals diagnosed with both ADHD and SAD experience greater social impairments (Herizchi & Vasfi, 2021; Jakobsson Støre et al., 2024), it is essential to address these comorbid diagnoses to help reduce symptoms and improve functioning. This presentation will review the current literature regarding the relationship between ADHD and SAD, discuss treatment modalities to address the co-occurring disorders, and outline specific interventions to help adults with ADHD and SAD reduce symptoms and improve function. This is an intermediate-level webinar appropriate for mental health and medical professionals who desire learning more about this topic.

Objectives:

1. Describe the relationship between ADHD and Social Anxiety Disorder (SAD) in adults and how these diagnoses impact relationships
2. Discuss treatment modalities that can address ADHD and SAD
3. Identify two interventions to support adults with ADHD and SAD

Non-Discrimination:

HPC and ATAGF do not discriminate on the basis of race, color, national origin, religion, sex, gender identity, disability, military status, sexual orientation, or age.

Conflict of Interest Statements:

There is no known commercial support for this program, nor are there any relationships between the CE sponsor, presenting organization, presenter, program content, research, grants, or other funding that could be construed as conflicts of interests. Dr. Hoff receives an honorarium for instructing this course. There is no commercial support or benefits for endorsement of products (e.g., books, training, drugs).

The presenter will inform participants of the utility and validity of content discussed (including the basis for statements about utility/validity), as well as limitations of the approach and the most common and severe risks, if any, associated with program content.

Requests for Accommodations:

HPC and ATAGF are committed to accessibility and non-discrimination in all aspects of its continuing education activities. Participants with special needs should contact program organizers so reasonable accommodations can be made.

To request accommodations, contact ATAGF's Continuing Education Vice Chair, Christine Boulton-Olson, PhD, LP, at [email protected].